Proteotoxic stress increases nuclear localization of ataxin-3

Human Molecular Genetics

Volumn 19, Issue 2, 2009, Pages 235-249

  Reina, Christopher P ^a   Zhong, Xiaoyan ^a   Pittman, Randall N ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIN 3; ATXN3 PROTEIN, HUMAN; DNA BINDING PROTEIN; NERVE PROTEIN; NUCLEAR PROTEIN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; RAD23B PROTEIN, HUMAN; REPRESSOR PROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MAPPING; GENE MUTATION; GENETIC ANALYSIS; HEAT SHOCK; HUMAN; HUMAN CELL; MACHADO JOSEPH DISEASE; MOLECULAR WEIGHT; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; SPINOCEREBELLAR DEGENERATION; STRESS; ANIMAL; CELL CULTURE; CELL LINE; CELL NUCLEUS; CHEMISTRY; GENETICS; HEAT SHOCK RESPONSE; METABOLISM; MOUSE; MOUSE MUTANT; PATHOPHYSIOLOGY; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; PROTEIN TRANSPORT;

ANIMALS; CELL LINE; CELL NUCLEUS; CELLS, CULTURED; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; FIBROBLASTS; HEAT-SHOCK RESPONSE; HUMANS; MACHADO-JOSEPH DISEASE; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; OXIDATIVE STRESS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; REPRESSOR PROTEINS;

EID: 77949450752     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddp482     Document Type: Article

References (65)

1. Orr, H.T. and Zoghbi, H.Y. (2007) Trinucleotide repeat disorders. Annu. Rev. Neurosci., 30, 575-621.
2. Paulson, H.L., Perez, M.K., Trottier, Y., Trojanowski, J.Q., Subramony, S.H., Das, S.S., Vig, P., Mandel, J.L., Fischbeck, K.H. and Pittman, R.N. (1997) Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron, 19, 333-344.
3. Davies, S.W., Turmaine, M., Cozens, B.A., DiFiglia, M., Sharp, A.H., Ross, C.A., Scherzinger, E., Wanker, E.E., Mangiarini, L. and Bates, G.P. (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell, 90, 537-548.
4. Cummings, C.J., Mancini, M.A., Antalffy, B., DeFranco, D.B., Orr, H.T. and Zoghbi, H.Y. (1998) Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat. Genet., 19, 148-154.
5. Perez, M.K., Paulson, H.L., Pendse, S.J., Saionz, S.J., Bonini, N.M. and Pittman, R.N. (1998) Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation. J. Cell Biol., 143, 1457-1470.
6. Kazantsev, A., Preisinger, E., Dranovsky, A., Goldgaber, D. and Housman, D. (1999) Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells. Proc. Natl. Acad. Sci. US A, 96, 11404-11409.
7. Chai, Y., Koppenhafer, S.L., Shoesmith, S.J., Perez, M.K. and Paulson, H.L. (1999) Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. Hum. Mol. Genet., 8, 673-682.
8. Kawaguchi, Y., Okamoto, T., Taniwaki, M., Aizawa, M., Inoue, M., Katayama, S., Kawakami, H., Nakamura, S., Nishimura, M., Akiguchi, I. et al. (1994) CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat. Genet., 8, 221-228.
9. Paulson, H.L., Das, S.S., Crino, P.B., Perez, M.K., Patel, S.C., Gotsdiner, D., Fischbeck, K.H. and Pittman, R.N. (1997) Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain. Ann. Neurol., 41, 453-462.
10. Tait, D., Riccio, M., Sittler, A., Scherzinger, E., Santi, S., Ognibene, A., Maraldi, N.M., Lehrach, H. and Wanker, E.E. (1998) Ataxin-3 is transported into the nucleus and associates with the nuclear matrix. Hum. Mol. Genet., 7, 991-997.
11. Trottier, Y., Cancel, G., An-Gourfinkel, I., Lutz, Y., Weber, C., Brice, A., Hirsch, E. and Mandel, J.L. (1998) Heterogeneous intracellular localization and expression of ataxin-3. Neurobiol. Dis., 5, 335-347.
12. Perez, M.K., Paulson, H.L. and Pittman, R.N. (1999) Ataxin-3 with an altered conformation that exposes the polyglutamine domain is associated with the nuclear matrix. Hum. Mol. Genet., 8, 2377-2385.
13. Saudou, F., Finkbeiner, S., Devys, D. and Greenberg, M.E. (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell, 95, 55-66.
14. Peters, M.F., Nucifora, F.C. Jr, Kushi, J., Seaman, H.C., Cooper, J.K., Herring, W.J., Dawson, V.L., Dawson, T.M. and Ross, C.A. (1999) Nuclear targeting of mutant Huntingtin increases toxicity. Mol. Cell. Neurosci., 14, 121-128.
15. Fujigasaki, H., Uchihara, T., Koyano, S., Iwabuchi, K., Yagishita, S., Makifuchi, T., Nakamura, A., Ishida, K., Toru, S., Hirai, S. et al. (2000) Ataxin-3 is translocated into the nucleus for the formation of intranuclear inclusions in normal and Machado-Joseph disease brains. Exp. Neurol., 165, 248-256.
16. Nucifora, F.C. Jr, Ellerby, L.M., Wellington, C.L., Wood, J.D., Herring, W.J., Sawa, A., Hayden, M.R., Dawson, V.L., Dawson, T.M. and Ross, C.A. (2003) Nuclear localization of a non-caspase truncation product of atrophin-1, with an expanded polyglutamine repeat, increases cellular toxicity. J. Biol. Chem., 278, 13047-13055.
17. Kretzschmar, D., Tschape, J., Bettencourt Da Cruz, A., Asan, E., Poeck, B., Strauss, R. and Pflugfelder, G.O. (2005) Glial and neuronal expression of polyglutamine proteins induce behavioral changes and aggregate formation in Drosophila. Glia, 49, 59-72.
18. Klement, I.A., Skinner, P.J., Kaytor, M.D., Yi, H., Hersch, S.M., Clark, H.B., Zoghbi, H.Y. and Orr, H.T. (1998) Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell, 95, 41-53.
19. Katsuno, M., Adachi, H., Kume, A., Li, M., Nakagomi, Y., Niwa, H., Sang, C., Kobayashi, Y., Doyu, M. and Sobue, G. (2002) Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron, 35, 843-854.
20. Bichelmeier, U., Schmidt, T., Hubener, J., Boy, J., Ruttiger, L., Habig, K., Poths, S., Bonin, M., Knipper, M., Schmidt, W.J. et al. (2007) Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence. J. Neurosci., 27, 7418-7428.
21. Li, F., Macfarlan, T., Pittman, R.N. and Chakravarti, D. (2002) Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor activities. J. Biol. Chem., 277, 45004-45012.
22. Evert, B.O., Vogt, I.R., Vieira-Saecker, A.M., Ozimek, L., de Vos, R.A., Brunt, E.R., Klockgether, T. and Wullner, U. (2003) Gene expression profiling in ataxin-3 expressing cell lines reveals distinct effects of normal and mutant ataxin-3. J. Neuropathol. Exp. Neurol., 62, 1006-1018.
23. Evert, B.O., Araujo, J., Vieira-Saecker, A.M., de Vos, R.A., Harendza, S., Klockgether, T. and Wullner, U. (2006) Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation. J. Neurosci., 26, 11474-11486.
24. Chou, A.H., Yeh, T.H., Ouyang, P., Chen, Y.L., Chen, S.Y. and Wang, H.L. (2008) Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation. Neurobiol. Dis., 31, 89-101.
25. Burnett, B., Li, F. and Pittman, R.N. (2003) The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity. Hum. Mol. Genet., 12, 3195-3205.
26. Scheel, H., Tomiuk, S. and Hofmann, K. (2003) Elucidation of ataxin-3 and ataxin-7 function by integrative bioinformatics. Hum. Mol. Genet., 12, 2845-2852.
27. Wang, G., Sawai, N., Kotliarova, S., Kanazawa, I. and Nukina, N. (2000) Ataxin-3, the MJD1 gene product, interacts with the two human homologs of yeast DNA repair protein RAD23, HHR23A and HHR23B. Hum. Mol. Genet., 9, 1795-1803.
28. Doss-Pepe, E.W., Stenroos, E.S., Johnson, W.G. and Madura, K. (2003) Ataxin-3 interactions with rad23 and valosin-containing protein and its associations with ubiquitin chains and the proteasome are consistent with a role in ubiquitin-mediated proteolysis. Mol. Cell. Biol., 23, 6469-6483.
29. Chai, Y., Berke, S.S., Cohen, R.E. and Paulson, H.L. (2004) Poly-ubiquitin binding by the polyglutamine disease protein ataxin-3 links its normal function to protein surveillance pathways. J. Biol. Chem., 279, 3605-3611.
30. Burnett, B.G. and Pittman, R.N. (2005) The polyglutamine neurodegenerative protein ataxin 3 regulates aggresome formation. Proc. Natl Acad. Sci. U S A, 102, 4330-4335.
31. Warrick, J.M., Morabito, L.M., Bilen, J., Gordesky-Gold, B., Faust, L.Z., Paulson, H.L. and Bonini, N.M. (2005) Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism. Mol. Cell., 18, 37-48.
32. Nicastro, G., Menon, R.P., Masino, L., Knowles, P.P., McDonald, N.Q. and Pastore, A. (2005) The solution structure of the Josephin domain of ataxin-3: structural determinants for molecular recognition. Proc. Natl Acad. Sci. U S A, 102, 10493-10498.
33. Mao, Y., Senic-Matuglia, F., Di Fiore, P.P., Polo, S., Hodsdon, M.E. and De Camilli, P. (2005) Deubiquitinating function of ataxin-3: insights from the solution structure of the Josephin domain. Proc. Natl Acad. Sci. U S A, 102, 12700-12705.
34. Zhong, X. and Pittman, R.N. (2006) Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates. Hum. Mol. Genet., 15, 2409-2420.
35. Wang, Q., Li, L. and Ye, Y. (2006) Regulation of retrotranslocation by p97-associated deubiquitinating enzyme ataxin-3. J. Cell Biol., 174, 963-971.
36. Rodrigues, A.J., Coppola, G., Santos, C., Costa Mdo, C., Ailion, M., Sequeiros, J., Geschwind, D.H. and Maciel, P. (2007) Functional genomics and biochemical characterization of the C. elegans orthologue of the Machado-Joseph disease protein ataxin-3. FASEB J., 21, 1126-1136.
37. Winborn, B.J., Travis, S.M., Todi, S.V., Scaglione, K.M., Xu, P., Williams, A.J., Cohen, R.E., Peng, J. and Paulson, H.L. (2008) The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits Lys63 linkages in mixed linkage ubiquitin chains. J. Biol. Chem., 283, 26436-26443.
38. Todi, S.V., Winborn, B.J., Scaglione, K.M., Blount, J.R., Travis, S.M. and Paulson, H.L. (2009) Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin-3. EMBO J., 28, 372-382.
39. Donaldson, K.M., Li, W., Ching, K.A., Batalov, S., Tsai, C.C. and Joazeiro, C.A. (2003) Ubiquitin-mediated sequestration of normal cellular proteins into polyglutamine aggregates. Proc. Natl Acad. Sci. USA, 100, 8892-8897.
40. Bertolaet, B.L., Clarke, D.J., Wolff, M., Watson, M.H., Henze, M., Divita, G. and Reed, S.I. (2001) UBA domains of DNA damage-inducible proteins interact with ubiquitin. Nat. Struct. Biol., 8, 417-422.
41. Wilkinson, C.R., Seeger, M., Hartmann-Petersen, R., Stone, M., Wallace, M., Semple, C. and Gordon, C. (2001) Proteins containing the UBA domain are able to bind to multi-ubiquitin chains. Nat. Cell. Biol., 3, 939-943.
42. Chen, L. and Madura, K. (2002) Rad23 promotes the targeting of proteolytic substrates to the proteasome. Mol. Cell. Biol., 22, 4902-4913.
43. Rao, H. and Sastry, A. (2002) Recognition of specific ubiquitin conjugates is important for the proteolytic functions of the ubiquitin-associated domain proteins Dsk2 and Rad23. J. Biol. Chem., 277, 11691-11695.
44. Mueller, T., Breuer, P., Schmitt, I., Walter, J., Evert, B.O. and Wullner, U. (2009) CK2-dependent phosphorylation determines cellular localization and stability of ataxin-3. Hum. Mol. Genet., 18, 3334-3343.
45. Macedo-Ribeiro, S., Cortes, L., Maciel, P. and Carvalho, A.L. (2009) Nucleocytoplasmic shuttling activity of ataxin-3. PLoS One., 4, e5834.
46. Antony, P.M., Mantele, S., Mollenkopf, P., Boy, J., Kehlenbach, R.H., Riess, O. and Schmidt, T. (2009) Identification and functional dissection of localization signals within ataxin-3. Neurobiol. Dis., 36, 280-292.
47. Westwood, J.T., Clos, J. and Wu, C. (1991) Stress-induced oligomerization and chromosomal relocalization of heat-shock factor. Nature, 353, 822-827.
48. Baler, R., Dahl, G. and Voellmy, R. (1993) Activation of human heat shock genes is accompanied by oligomerization, modification, and rapid translocation of heat shock transcription factor HSF1. Mol. Cell. Biol., 13, 2486-2496.
49. Sarge, K.D., Murphy, S.P. and Morimoto, R.I. (1993) Activation of heat shock gene transcription by heat shock factor 1 involves oligomerization, acquisition of DNA-binding activity, and nuclear localization and can occur in the absence of stress. Mol. Cell. Biol., 13, 1392-1407.
50. Guettouche, T., Boellmann, F., Lane, W.S. and Voellmy, R. (2005) Analysis of phosphorylation of human heat shock factor 1 in cells experiencing a stress. BMC Biochem., 6,4.
51. Kim, S.A., Yoon, J.H., Lee, S.H. and Ahn, S.G. (2005) Polo-like kinase 1 phosphorylates heat shock transcription factor 1 and mediates its nuclear translocation during heat stress. J. Biol. Chem., 280, 12653-12657.
52. Nakajima, H., Toyoshima-Morimoto, F., Taniguchi, E. and Nishida, E. (2003) Identification of a consensus motif for Plk (Polo-like kinase) phosphorylation reveals Myt1 as a Plk1 substrate. J. Biol. Chem., 278, 25277-25280.
53. Johnson, E.F., Stewart, K.D., Woods, K.W., Giranda, V.L. and Luo, Y. (2007) Pharmacological and functional comparison of the polo-like kinase family: insight into inhibitor and substrate specificity. Biochemistry, 46, 9551-9563.
54. Perez-Severiano, F., Rios, C. and Segovia, J. (2000) Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington's disease. Brain Res., 862, 234-237.
55. Bogdanov, M.B., Andreassen, O.A., Dedeoglu, A., Ferrante, R.J. and Beal, M.F. (2001) Increased oxidative damage to DNA in a transgenic mouse model of Huntington's disease. J. Neurochem., 79, 1246-1249.
56. Perluigi, M., Poon, H.F., Maragos, W., Pierce, W.M., Klein, J.B., Calabrese, V., Cini, C., De Marco, C. and Butterfield, D.A. (2005) Proteomic analysis of protein expression and oxidative modification in r6/2 transgenic mice: a model of Huntington disease. Mol. Cell. Proteomics., 4, 1849-1861.
57. Miyata, R., Hayashi, M., Tanuma, N., Shioda, K., Fukatsu, R. and Mizutani, S. (2008) Oxidative stress in neurodegeneration in dentatorubral-pallidoluysian atrophy. J. Neurol. Sci., 264, 133-139.
58. Yu, Y.C., Kuo, C.L., Cheng, W.L., Liu, C.S. and Hsieh, M. (2009) Decreased antioxidant enzyme activity and increased mitochondrial DNA damage in cellular models of Machado-Joseph disease. J. Neurosci. Res., 87, 1884-1891.
59. Beal, M.F. (1998) Mitochondrial dysfunction in neurodegenerative diseases. Biochim. Biophys. Acta., 1366, 211-223.
60. Balch, W.E., Morimoto, R.I., Dillin, A. and Kelly, J.W. (2008) Adapting proteostasis for disease intervention. Science., 319, 916-919.
61. Morimoto, R.I. (2008) Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes. Dev., 22, 1427-1438.
62. Hetz, C. and Glimcher, L.H. (2009) Fine-tuning of the unfolded protein response: assembling the IRE1alpha interactome. Mol. Cell., 35, 551-561.
63. Stommel, J.M., Marchenko, N.D., Jimenez, G.S., Moll, U.M., Hope, T.J. and Wahl, G.M. (1999) A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J., 18, 1660-1672.
64. Seeburg, D.P., Pak, D. and Sheng, M. (2005) Polo-like kinases in the nervous system. Oncogene, 24, 292-298.
65. Atwal, R.S., Xia, J., Pinchev, D., Taylor, J., Epand, R.M. and Truant, R. (2007) Huntingtin has a membrane association signal that can modulate huntingtin aggregation, nuclear entry and toxicity. Hum. Mol. Genet., 16, 2600-2615.